Fletcher/CSI Blog January 2025 Biotech Highlights: What's Ahead for 2025 post-JPMorgan

By Tina Witte, SVP of Life Sciences The energy, excitement, and deal volumes at this year's JPM Morgan Healthcare conference always set the tone for what is to come in the year ahead. Outside of the big pharma M&A and announcements, there is much to discern on what is happening in the innovative biotech READ MOREThe post January 2025 Biotech Highlights: What's Ahead for 2025 post-JPMorgan appeared first on Fletcher - Global Primary Research.